Pharmaceutical innovation in the APAC region

The Asia Pacific (APAC)'s pharmaceutical industry is expected to reach a total value of $ 482.6 billion by 2025 and the region continues to attract multinational pharmaceutical firms that invest in the market. Governments have announced more expansive healthcare budgets and the integration of advanced technologies into health systems. Countries with growing population creates increased demand for generic drugs, while countries that face aging population suggest high interest in innovative and branded drugs.

Each year CPHI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market. Hosting events in Europe, China, Korea, India, Japan, South East Asia, Middle East and North America, CPHI co-locates with ICSE for contract services, P-MEC for machinery, equipment and technology, InnoPack for pharmaceutical packaging, Bioproduction for biopharma and FDF for every aspect of the finished dosage supply chain.

Are you interested in attending or exhibiting at CPHI events in Asia? Click Here